Cargando…
A phase Ib/IIa clinical trial of dantrolene sodium in patients with Wolfram syndrome
BACKGROUND: Wolfram syndrome is a rare ER disorder characterized by insulin-dependent diabetes mellitus, optic nerve atrophy, and progressive neurodegeneration. Although there is no treatment for Wolfram syndrome, preclinical studies in cell and rodent models suggest that therapeutic strategies targ...
Autores principales: | Abreu, Damien, Stone, Stephen I., Pearson, Toni S., Bucelli, Robert C., Simpson, Ashley N., Hurst, Stacy, Brown, Cris M., Kries, Kelly, Onwumere, Chinyere, Gu, Hongjie, Hoekel, James, Tychsen, Lawrence, Van Stavern, Gregory P., White, Neil H., Marshall, Bess A., Hershey, Tamara, Urano, Fumihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410026/ https://www.ncbi.nlm.nih.gov/pubmed/34185708 http://dx.doi.org/10.1172/jci.insight.145188 |
Ejemplares similares
-
Visual pathway function and structure in Wolfram syndrome: patient age, variation and progression
por: Hoekel, James, et al.
Publicado: (2018) -
Early presentation of gait impairment in Wolfram Syndrome
por: Pickett, Kristen A, et al.
Publicado: (2012) -
Genotype and Clinical Characteristics of Patients with Wolfram Syndrome and WFS1-related Disorders
por: Lee, Evan M., et al.
Publicado: (2023) -
Genotype and clinical characteristics of patients with Wolfram syndrome and WFS1-related disorders
por: Lee, Evan M., et al.
Publicado: (2023) -
Phenotypic characteristics of early Wolfram syndrome
por: Marshall, Bess A, et al.
Publicado: (2013)